Margaret Tooth Sells 4,000 Shares of Trupanion, Inc. (NASDAQ:TRUP) Stock

Trupanion, Inc. (NASDAQ:TRUP) CEO Margaret Tooth sold 4,000 shares of Trupanion stock in a transaction that occurred on Thursday, March 20th. The shares were sold at an average price of $37.17, for a total transaction of $148,680.00. Following the transaction, the chief executive officer now directly owns 118,784 shares of the company’s stock, valued at approximately $4,415,201.28. This trade represents a 3.26 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link.

Margaret Tooth also recently made the following trade(s):

• On Tuesday, March 4th, Margaret Tooth sold 2,294 shares of Trupanion stock. The shares were sold at an average price of $31.39, for a total transaction of $72,008.66.

Trupanion Price Performance

Shares of TRUP stock traded up $1.61 on Monday, reaching $38.61. 457,442 shares of the company were exchanged, compared to its average volume of 639,547. The business has a 50-day moving average price of $41.64 and a 200 day moving average price of $46.74. Trupanion, Inc. has a 1 year low of $19.69 and a 1 year high of $57.90. The company has a market cap of $1.64 billion, a price-to-earnings ratio of -167.87, a P/E/G ratio of 6.02 and a beta of 1.70. The company has a debt-to-equity ratio of 0.39, a quick ratio of 1.66 and a current ratio of 1.71.

Trupanion (NASDAQ:TRUP) last issued its earnings results on Wednesday, February 19th. The financial services provider reported $0.04 EPS for the quarter, missing analysts’ consensus estimates of $0.06 by ($0.02). The business had revenue of $337.31 million during the quarter, compared to analyst estimates of $335.41 million. Trupanion had a negative net margin of 0.75% and a negative return on equity of 3.08%. Equities research analysts forecast that Trupanion, Inc. will post 0.13 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

TRUP has been the topic of several recent analyst reports. Piper Sandler lowered their target price on shares of Trupanion from $57.00 to $52.00 and set an “overweight” rating on the stock in a research note on Thursday, February 20th. Stifel Nicolaus lowered their price target on Trupanion from $44.00 to $41.00 and set a “hold” rating on the stock in a research report on Thursday, February 20th. Two research analysts have rated the stock with a hold rating, four have given a buy rating and one has given a strong buy rating to the company. According to MarketBeat, Trupanion currently has a consensus rating of “Moderate Buy” and an average target price of $46.60.

Institutional Trading of Trupanion

Large investors have recently added to or reduced their stakes in the stock. Victory Capital Management Inc. purchased a new stake in shares of Trupanion in the 3rd quarter valued at approximately $261,000. Mutual of America Capital Management LLC acquired a new position in Trupanion during the 3rd quarter worth $210,000. Quest Partners LLC purchased a new stake in shares of Trupanion during the third quarter worth approximately $37,000. Intech Investment Management LLC raised its holdings in shares of Trupanion by 73.6% in the 3rd quarter. Intech Investment Management LLC now owns 17,208 shares of the financial services provider’s stock valued at $722,000 after purchasing an additional 7,298 shares in the last quarter. Finally, Landscape Capital Management L.L.C. purchased a new stake in Trupanion during the 3rd quarter worth about $698,000.

Trupanion Company Profile

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.